MUSCLE LOSS DURING NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITHIN THE PREOPANC-2 STUDY PREDICTS OVERALL SURVIVAL

Name: MUSCLE LOSS DURING NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITHIN THE PREOPANC-2 STUDY PREDICTS OVERALL SURVIVAL
Start: 2026-09-07T11:33:00+02:00
End: 2026-09-07T11:42:00+02:00

Sep 7, 2026 — 11:33 am - 11:42 AM
Convention Hall A

Main Session

Presenter:

Nicole HILDEBRAND (Germany)

O048

MUSCLE LOSS DURING NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITHIN THE PREOPANC-2 STUDY PREDICTS OVERALL SURVIVAL

Parent session

11:15 AM12:00 PM

Online

ESPEN best abstracts

Kristina NORMANCharite and DIfE - NUTRITION AND GERONTOLOGYMireille SERLIEYale School of Medicine

MUSCLE LOSS DURING NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITHIN THE PREOPANC-2 STUDY PREDICTS OVERALL SURVIVAL

Sep 7, 2026 — 11:33 am - 11:42 AMConvention Hall A

ESPEN best abstracts

Sep 7, 2026 — 11:33 am - 11:42 AM
Convention Hall A